Filter by ContentType
Virtual Think-Tank on AAV vectors
31 October 2022
Expert Roundtable Video
Thinking big: the need for innovation in the production of lentivirus-based cell and gene therapies
H Leinonen, J Moscariello, L Davies et al
20 April 2022
Expert Roundtable Video
Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow
Isabelle Riviére, Metin Kurtoglu, Tariq Haq
22 November 2021
Expert Roundtable Video
Expert Roundtable: Evolution in AAV process development: 2022 and beyond
Alejandro Becerra, Matthias Hebben, Michael Mercaldi
12 October 2021
Expert Roundtable Video
Expert Roundtable: leveraging cutting edge tools to convert I-O data into knowledge
Anil K Sood
12 October 2021
Expert Roundtable Video
Expert Roundtable: overcoming challenges in analytical assays for cellular therapies
Jara Joedicke, Eric Alonzo, Marsilius Mues
12 October 2021
Expert Roundtable Video
Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?
27 September 2021
Expert Roundtable Video
Enhancing preclinical predictivity in I-O: what is going wrong between preclinical in vitro/in vivo and clinical settings?
P Ellmark, D Gilham, M Steegmaier et al
05 August 2021
Expert Roundtable Video
Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?
D Adil Daud, S Fling, PhD, J Rossi et al
09 June 2021
Expert Roundtable Video
Embracing transformation: how big data, AI and digitization are changing cell and gene therapy manufacture
14 May 2021
Expert Roundtable Video
How to increase I-O manufacturing efficiency, flexibility, and productivity in line with expected future trends in supply and demand?
John Lunger, Vijay Yabannavar, Donna Rill
22 April 2021
Expert Roundtable Video
Viral vector production process intensification: analytics, automation, in-line testing, and more
S D’Costa, M Delahaye, M DiBiasio-White et al
18 January 2021
Expert Roundtable Video
Streamlining and optimizing viral vector bioprocess and analytical development
J Tarnowski, N Kotsopoulou, K Patel et al
22 December 2020
Expert Roundtable Video
Expert Roundtable: Clinical success of checkpoint inhibitors: what's next for combination therapy in I-O?
J J Luke, J Fairchild , R Taylor et al
08 October 2020
Expert Roundtable Video
Expert Roundtable: getting a gene therapy product to market: pitfalls and how to prevent them
Hetal Brahmbhatt, Thomas Guarinoni, Elizabeth Simmons
22 September 2020
Expert Roundtable Video
Expert Roundtable: evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting
D Adams, G Russotti, E Fearnot et al
17 July 2020
Expert Roundtable Video
Regulatory FAQs & common concerns for cell & gene therapy raw & starting materials – on demand webinar
Kasey Kime, Jerrod Denham, Christopher Bravery
27 April 2020
Expert Roundtable Video
Expert Roundtable: overcoming raw material challenges in cell & gene therapy manufacturing
David DiGiusto, Bernd Leistler, Tom Walls
14 April 2020
Expert Roundtable Video
Expert Roundtable: Scale-up considerations for improved yield in upstream viral vector production
S Ansorge, M Burnham, M Kelly et al
17 February 2020
Expert Roundtable Video
Expert Roundtable: Critical needs & challenges for the cell & gene therapy raw materials supply chain
S Baila, M Frechette, D Goel et al
11 November 2019
Expert Roundtable Video
The power and potential of T-cell therapies – Elisa Manzotti talks with Dr Carl June
09 September 2019
Expert Roundtable Video